Publications by authors named "Medhi Khellaf"

Claim this Profile
V
Vincristine efficacy and safety in treating immune thrombocytopenia: a retrospective study of 35 patients.
Jérôme Stirnemann, Najett Kaddouri, Medhi Khellaf, Anne-Sophie Morin, Virginie Prendki

Eur J Haematol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature.
Romain Levy, Matthieu Mahévas, Lionel Galicier, David Boutboul, Julien Moroch, Medhi Khellaf

Autoimmun Rev· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding.
David Grimaldi, Florence Canouï-Poitrine, Laure Croisille, Ketty Lee, Françoise Roudot-Thoraval, Medhi Khellaf

Ann Hematol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia.
Matthieu Mahévas, Mikael Ebbo, Sylvain Audia, Bernard Bonnotte, Nicolas Schleinitz, Medhi Khellaf

Am J Hematol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients.
Matthieu Mahévas, Laurent Chiche, Yurdagul Uzunhan, Medhi Khellaf, Anne Sophie Morin

Medicine (Baltimore)· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis